Live attenuated measles virus ≥1,000 CCID50, rubella virus 1,000 CCID50
Indications/Uses
Active immunization against measles & rubella in childn aged 9 mth-16 yr.
Dosage/Direction for Use
SC 0.5 mL.
Contraindications
Anaphylactic or anaphylactoid reactions to neomycin; history of anaphylactic or anaphylactoid reactions. Febrile states; acute infectious diseases, leukaemia, severe anaemia & other severe diseases of the blood system; decompensated heart disease. Following administration of gammaglobulin or blood transfusions. Concomitantly receiving corticosteroids or other immunosuppressive drugs; undergoing RT. Severe renal impairment. Pregnancy.
Adverse Reactions
Mild pain at inj site, mild fever 7-12 days after vaccination & lasting 2 days, arthralgia & arthritis lasting from a few days to 2 wk.
Sign Out
